Bollard Group’s MetLife MET Stock Holding History

Bollard Group’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-156	Closed	-$10K	–	313
2023 Q3	$10K	Buy	156 +1	+0.6%	+$62	﹤0.01%	265
2023 Q2	$9K	Buy	+155	New	+$8.6K	﹤0.01%	314

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Bollard Group's MET Position: Q4 2023 in Review

Bollard Group sold out of MetLife (MET) in Q4 2023, closing a stake of 156 shares — an estimated $10K sold.

Bollard Group first reported a position in MET in Q2 2023 and held it in 2 quarters. The position peaked at $10K in Q3 2023. 1,262 funds tracked by Wall St. Rank hold MET as of Q4 2023.

Bollard Group reported no remaining MetLife position as of Q4 2023 after selling out during the quarter.
Bollard Group sold 156 MetLife shares in Q4 2023, an estimated $10K.
Bollard Group first reported a position in MetLife in Q2 2023 and held it in 2 quarters.
Bollard Group's MetLife position peaked at $10K in Q3 2023.
1,262 funds tracked by Wall St. Rank held MetLife as of Q4 2023.

Based on Bollard Group's 13F filing for Q4 2023, filed 13 Feb 2024.